![John Aballi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Aballi
Vorstandsvorsitzender bei
EXAGEN INC.
Vermögen: 2 Mio $ am 31.07.2026
Profil
John Aballi is President, Chief Executive Officer & Director at Exagen, Inc. since 2024.
Former roles include Director at PFS Genomics, Inc., Head-Laboratory & Cartesian Operations at Genoptix, Inc. from 2007 to 2015, SVP, General Manager, COO-Urology & CLIA at Veracyte, Inc., Chief Operating Officer at Veracyte SD, Inc. from 2018 to 2021, and Head-Operations at Molecular Stethoscope, Inc. from 2015 to 2018.
Education includes an MBA from California Baptist University and undergraduate studies at the University of California San Diego.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EXAGEN, INC. 2,12 % | 15.04.2026 | 511 261 ( 2,12 % ) | 2 Mio $ | 31.07.2026 |
Aktive Positionen von John Aballi
| Unternehmen | Position | Beginn |
|---|---|---|
| EXAGEN INC. | Vorstandsvorsitzender | 17.10.2022 |
Ehemalige bekannte Positionen von John Aballi
| Unternehmen | Position | Ende |
|---|---|---|
Veracyte SD, Inc.
 Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care | Geschäftsführer | 01.03.2021 |
PFS Genomics, Inc.
 PFS Genomics, Inc. Hospital/Nursing ManagementHealth Services Provides breast cancer radiotherapy treatment services | Direktor/Vorstandsmitglied | 01.01.2021 |
Molecular Stethoscope, Inc.
 Molecular Stethoscope, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostic and transcriptomic research services | Corporate Officer/Principal | 01.08.2018 |
Genoptix, Inc.
 Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Corporate Officer/Principal | 01.09.2015 |
| VERACYTE, INC. | Corporate Officer/Principal | - |
Ausbildung von John Aballi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Genoptix, Inc.
Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Health Services |
Veracyte, Inc.
 Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
California Baptist University
 California Baptist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exagen, Inc.
 Exagen, Inc. Medical/Nursing ServicesHealth Services Operates as a commercial-stage diagnostics company | Health Services |
Veracyte SD, Inc.
Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care | Commercial Services |
Molecular Stethoscope, Inc.
Molecular Stethoscope, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostic and transcriptomic research services | Health Services |
PFS Genomics, Inc.
PFS Genomics, Inc. Hospital/Nursing ManagementHealth Services Provides breast cancer radiotherapy treatment services | Health Services |
